Columbia, MD, United States
Columbia, MD, United States

Time filter

Source Type

Bruins M.J.,Royal DSM | Dane A.D.,Leiden University | Strassburg K.,Leiden University | Vreeken R.J.,Leiden University | And 5 more authors.
Journal of Lipid Research | Year: 2013

The dose-responsiveness of plasma oxylipins to incremental dietary intake of arachidonic acid (20:4n-6; ARA) and docosahexaenoic acid (22:6n-3; DHA) was determined in piglets. Piglets randomly received one of six formulas (n = 8 per group) from days 3 to 27 postnatally. Diets contained incremental ARA or incremental DHA levels as follows (% fatty acid, ARA/DHA): (A1) 0.1/1.0; (A2) 0.53/1.0; (A3-D3) 0.69/1.0; (A4) 1.1/1.0; (D1) 0.66/0.33; and (D2) 0.67/0.62, resulting in incremental intake (g/kg BW/day) of ARA: 0.07 ± 0.01, 0.43 ± 0.03, 0.55 ± 0.03, and 0.82 ± 0.05 at constant DHA intake (0.82 ± 0.05), or incremental intake of DHA: 0.27 ± 0.02, 0.49 ± 0.03, and 0.81 ± 0.05 at constant ARA intake (0.54 ± 0.04). Plasma oxylipin concentrations and free plasma PUFA levels were determined at day 28 using LC-MS/MS. Incremental dietary ARA intake dose-dependently increased plasma ARA levels. In parallel, ARA intake dose-dependently increased ARA-derived diols 5,6- and 14,15- dihydroxyeicosatrienoic acid (DiHETrE) and linoleic acid-derived 12,13-dihydroxyoctadecenoic acid (DiHOME), downstream metabolites of cytochrome P450 expoxygenase (CYP). The ARA epoxide products from CYP are important in vascular homeostatic maintenance. Incremental DHA intake increased plasma DHA and most markedly raised the eicosapentaenoic acid (EPA) metabolite 17,18-dihydroxyeicosatetraenoic acid (DiHETE) and the DHA metabolite 19,20-dihydroxydocosapentaenoic acid (DiHDPE). In conclusion, increasing ARA and DHA intake dose-dependently influenced endogenous n-6 and n-3 oxylipin plasma concentrations in growing piglets, although the biological relevance of these findings remains to be determined.

Wijendran V.,Harvard University | Downs I.,Cornell University | Downs I.,Yeshiva University | Srigley C.T.,Cornell University | And 9 more authors.
Prostaglandins Leukotrienes and Essential Fatty Acids | Year: 2013

Molecular regulation of fatty acid desaturase (Fads) gene expression by dietary arachidonic acid (ARA) and docosahexaenoic acid (DHA) during early post-natal period, when the demand for long chain polyunsaturated fatty acids (LC-PUFA) is very high, has not been well defined. The objective of the current study was to determine regulation of liver Fads1, Fads2 and Fads3 classical (CS) and alternative transcripts (AT) expression by dietary ARA and DHA, within the physiological range present in human breast milk, in suckling piglets. Piglets were fed one of six milk replacer formula diets (formula-reared groups, FR) with varying ARA and DHA content from days 3-28 of age. The ARA/DHA levels of the six formula diets were as follows (% total fatty acid, FA/FA): (A1) 0.1/1.0; (A2) 0.53/1.0; (A3-D3) 0.69/1.0; (A4) 1.1/1.0; (D2) 0.67/0.62; and (D1) 0.66/0.33. The control maternal-reared (MR) group remained with the dam. Fads1 expression was not significantly different between FR and MR groups. Fads2 expression was down-regulated significantly in diets with 1:1 ratio of ARA:DHA, compared to MR. Fads2 AT1 expression was highly correlated to Fads2 expression. Fads3 AT7 was the only Fads3 transcript sensitive to dietary LC-PUFA intake and was up-regulated in the formula diets with lowest ARA and DHA contents compared to MR. Thus, the present study provides evidence that the proportion of dietary ARA:DHA is a significant determinant of Fads2 expression and LC-PUFA metabolism during the early postnatal period. Further, the data suggest that Fads3 AT7 may have functional significance when dietary supply of ARA and DHA are low during early development. © 2013 Elsevier Ltd.

Kuratko C.N.,DSM Nutritional Lipids | Salem N.,DSM Nutritional Lipids
European Journal of Lipid Science and Technology | Year: 2013

Certain algae produce long chain omega-3 fatty acids including eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids as part of normal metabolism. In nature, these fatty acids enter the food chain and are important nutrients for the health of many animals, including humans. Cultured under specific and tightly controlled conditions, these oils are commercially produced for use in infant formula, foods, beverages, and a variety of supplements. EPA and DHA have long been associated with cardiovascular health. More recently the impact of DHA, as the primary n-3 fatty acid in brain and retinal tissue, has been documented. Within membranes, DHA facilitates cell signaling and serves as a precursor to highly bioactive molecules. Because endogenous production is low, levels of DHA in brain, retina, and other tissues do not reach higher levels unless this preformed fatty acid is included in the diet. Most Westernized diets provide low levels of EPA and DHA, making their use in supplements and fortified foods necessary for optimal health. © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Loading DSM Nutritional Lipids collaborators
Loading DSM Nutritional Lipids collaborators